Ever wondered if it's ever going to be possible to get in front of disease? Help is on the way. Today Probius emerges, and announces John Baldoni as CSO and Juan Cuevas as SVP Mktg & BizDev. fluent-pr.prowly.com/203279-probius…

When you’re changing the way #bioanalysis is done through bridging #biology and #ai, you need deep thinkers with deep connections on your BoD. Probius is proud to add John J. MacWilliams (LLNL Computing among others) and Janis Naeve, PhD (Cota Capital and @amgen Ventures).

Our commercialization will benefit greatly from Janis’ guidance within the biotechnology market and for biochemical applications. John’s insights into the transformational impact that high-fidelity data can have will help fuel the AI revolution from... businesswire.com/news/home/2022…

There’s no doubt AI will not only improve healthcare, but will also cut healthcare costs. Accenture estimates that AI applications will cut annual US healthcare costs by $150 B by 2026. #Healthcare #AI

Applied machine/deep learning & #lifesciences are coming together to transform how we understand & improve health. We want to partner w/ teams focused on building wet/dry lab platforms & novel datasets to disrupt traditional drug discovery processes. bit.ly/3FTANT5

It's the last day of #ACSFall2023! Come see #Probius and learn more about how #AI is impacting the #Bioanalytical space with #QES, a bench-top solution that's reagent- and sample prep- less to simplify analytical development​. Booth 1558, just outside the Expo Theatre.